Lucas A, Schackman BR, Ross EL, Yazdanpanah Y, Paltiel AD. The cost-effectiveness of targeting HIV pre-exposure prophylaxis based on partner treatment status in men who have sex with men in the US. Poster presented at the 36th Annual North American Meeting of the Society for Medical Decision Making; October 22, 2014. Miami, FL.
Brogan AJ, Smets E, Mauskopf JA, Manuel SA, Adriaenssen I. Cost-effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada. Pharmacoeconomics. 2014 Sep;32(9):903-17.
Wilkins E, Fisher M, Brogan AJ, Talbird SE. An analysis of cost and health outcomes associated with tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the United Kingdom. Poster presented at the 20th International AIDS Conference; July 20, 2014.
Puig-Barbera J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, Buiques-Vila A, Martinez-Ubeda S, Sominina A, GIHSN Group. 2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network. PLoS One. 2014 Jun 19;9(6):e100497.
Puig-Barbera J, Tormos A, Sominina A, Burtseva E, Launay O, Ciblak MA, Navtividad-Sancho A, Buigues-Vila A, Martinez-Ubeda S, Mahe C, GIHSN Group. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season. BMC Public Health. 2014 Jun 5;14:564. doi: 10.1186/1471-2458-14-564.
Davis KL, Kurosky SK. Recent trends in incidence of infant pertussis hospitalization in the United States. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Davis KL, Kurosky SK. Recent trends in costs, length of stay, and mortality associated with infant pertussis hospitalization in the United States. Presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Kurosky SK, Davis KL, Karve SJ. Tetanus toxoid, reduced diphtheria toxoid, and acellular puertussis (TDAP) vaccine compliance among adolescents in the United States, 2010-2012. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Wilkins E, Fisher M, Brogan AJ, Talbird SE. Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naive adults with HIV-1 infection in the United Kingdom. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014. [abstract] Value Health. 2014 May; 17(3):A276.
Karve SJ, Krishnarajah G, Korsnes JS, Cassidy A, Candrilli SD. Burden of acute gastroenteritis, norovirus and rotavirus in a managed care population. Hum Vaccin Immunother. 2014 Apr;10:1544-66. doi: 10.4161/hv.28704
Fletcher FE, Vidrine DJ, Tami-Maury I, Danysh HE, King RM, Buchberg M, Arduino RC, Gritz ER. Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic. AIDS Behav. 2014 Mar;18(3):544-54. doi: 10.1007/s10461-013-0480-6
Poulos C, Malik R, Guh S, Utomo N, Nyamete A. Household demand for typhoid fever vaccines in North Jakarta, Indonesia. Presented at the 1st Vaccine Congress; December 2007.
Talbird SE, Brogan AJ, Winiarski AP, Sander B. The cost-effectiveness of treating influenza-like illness with oseltamivir in the US. Poster presented at the 42nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists; December 2007.
Marton J, Jackel J, Carson R, Rothermel C, Menzin J. Predictors of costs for skin and skin structure infections due to staphylococcus aureus using a managed-care perspective. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland. [abstract] Value Health. 2007 Nov; 10(6):A446.
Earnshaw SR, Graham CN, Gasper S. Cost-effectiveness of anidulafungin therapy in confirmed candidemia and other forms of invasive candidiasis. Poster presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 2007.
Earnshaw SR, Hicks K, Richter A, Honeycutt A. A linear programming model for allocating HIV prevention funds with state agencies: a pilot study. Health Care Manag Sci. 2007 Sep 1;10(3):239-52.
Menzin J, Jackel J, Friedman M, Perfect J, Langston A, Danna R, Papadopoulos G. Clinical and economic burden of invasive fungal infections among hospitalized patients: findings from a U.S. national database. O-1869. Poster presented at the 47th Intersciences Conference on Antimicrobial Agents and Chemotherapy Meeting of the American Society for Microbiology; September 2007.
Gilsenan AW, Wang J, Midkiff KD, Andrews EB. Impact of potential selection bias on prevalence estimates of lower urinary tract symptoms in a primary care setting. Presented at the 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 21, 2007. Quebec City, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2007 Aug 7; 16(Suppl 2):S55. doi: 10.1002/pds.1461
Beach RH, Poulos C, Pattanayak SK. Agricultural household response to avian influenza prevention and control policies. J Agr Appl Econ. 2007 Aug 1;39(2):301-11.
Hicks KA, Honeycutt A. A high cost to missing the mark: dealing with uncertainty in hiv prevention resource allocation. Poster presented at the Informs International Conference; July 2007.
Pattanayak SK, Poulos C, Van Houtven GL, Yang J, Wendland KJ. Modeling self-protective behaviors against infectious disease: estimates of "prevalence elasticity" for malaria. Poster presented at the 6th World Congress of the International Health Economics Association: Explorations in Health; July 2007.
Mauskopf J, Brogan AJ, Malmberg C, Hwang P. Cost-effectiveness of darunavir for the management of HIV-infected, treatment-experienced adults in Canada. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. Previously presented at the 16th Annual Canadian Conference on HIV/AIDS Research.
Mauskopf JA, Brogan AJ, Malmberg C, Hwang P. A Canadian cost-effectiveness analysis of darunavir for HIV infection in treatment-experienced adults. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 2007. Arlington, VA. [abstract] Value Health. 2007 May; 10(3):A163.
Brogan AJ, Mauskopf JA, Martin S, Smets E. Cost-effectiveness analysis of darunavir/r for HIV infection in treatment-experienced adults in the US: understanding the uncertainty in the estimates. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 2007. Arlington, VA.
Mauskopf J, Brogan AJ, Malmberg C, Hwang P. Cost-effectiveness of darunavir for the management of HIV-infected, treatment-experienced adults in Canada. Poster presented at the 16th Annual Canadian Conference on HIV/AIDS Research; April 29, 2007.
Earnshaw SR, Sikirica V, Roskell NS, Shannon PR, Beard S, Schein J, Doshi D, Janagap C. Economic analysis of short-course levofloxacin versus amoxicillin/clavulanate in treating acute bacterial exacerbations of chronic bronchitis. Poster presented at the Academy of Managed Care Pharmacy 19th Annual Meeting Showcase; April 14, 2007.
Mahon BE, Ehrenstein V, Norgaard M, Pedersen L, Rothman KJ, Sorensen HT. Perinatal risk factors for hospitalization for pneumococcal disease in childhood: a population-based cohort study. Pediatrics. 2007 Apr 1;119(4):e804-12.
Beach RH, Poulos C, Pattanayak SK. Agricultural household response to avian influenza prevention and control policies. Poster presented at the Annual Meetings of the Southern Agricultural Economics Association; February 2007. Mobile, AL.